BriaCell Therapeutics
Quarterly Financials
| Values in thousands | 2025-04-30 | 2025-01-31 | 2024-10-31 | 2024-07-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -6,161 | -7,143 | -5,126 | -5,696 |
EBIT | -6,187 | -7,169 | -5,152 | -5,768 |
Net Income | -6,126 | -6,291 | -5,802 | -1,214 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -7,162 | -5,920 | -6,955 | -4,035 |
Cash | 12,460 | 5,013 | 5,792 | 862 |
Basic Shares | 3 | 18,028 | 18,028 | 18,028 |
Annual Financials
| Values in thousands | 2024-07-31 | 2023-07-31 | 2022-07-31 | 2021-07-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -20 | -19 | -19 | |
EBITDA | -4,791 | -27,221 | -34,047 | -6,954 |
EBIT | -27,236 | -34,066 | -6,973 | |
Net Income | -4,791 | -20,302 | -11,581 | -2,895 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -24,582 | -23,744 | -12,484 | -7,747 |
Cash | 862 | 21,251 | 41,041 | 57,268 |
Basic Shares | 16,454 | 15,620 | 15,518 | 15,270 |
